• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓栓塞 30 年后的死亡率:一项基于人群的队列研究。

30-year mortality after venous thromboembolism: a population-based cohort study.

机构信息

From the Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Circulation. 2014 Sep 2;130(10):829-36. doi: 10.1161/CIRCULATIONAHA.114.009107. Epub 2014 Jun 26.

DOI:10.1161/CIRCULATIONAHA.114.009107
PMID:24970783
Abstract

BACKGROUND

Studies on long-term mortality after venous thromboembolism (VTE) are sparse.

METHODS AND RESULTS

Using Danish medical databases, we conducted a 30-year nationwide population-based cohort study of 128 223 patients with first-time VTE (1980-2011) and a comparison cohort of 640 760 people from the general population (without VTE) randomly matched by sex, year of birth, and calendar period. The mortality risks for patients with deep venous thrombosis (DVT) and pulmonary embolism (PE) were markedly higher than for the comparison cohort during the first year, especially within the first 30 days (3.0% and 31% versus 0.4%). Using Cox regression, we assessed mortality rate ratios (MRRs) with 95% confidence intervals (CIs). The overall 30-year MRR was 1.55 (95% CI, 1.53-1.57) for DVT and 2.77 (95% CI, 2.74-2.81) for PE. The 30-day MRR was 5.38 (95% CI, 5.00-5.80) for DVT and 80.87 (95% CI, 76.02-86.02) for PE. Over time, the 30-day MRR was consistently 5- to 6-fold increased for DVT, whereas it improved for PE from 138 (95% CI, 125-153) in 1980 to 1989 to 36.08 (95% CI, 32.65-39.87) in 2000 to 2011. The 1- to 10-year and 11- to 30-year MRRs remained 25% to 40% increased after both DVT and PE but were 3- to 5-fold increased after DVT and 6- to 11-fold increased after PE when VTE was considered the immediate cause of death.

CONCLUSIONS

Patients with VTE are at increased risk of dying, especially within the first year after diagnosis, but also during the entire 30 years of follow-up, with VTE as an important cause of death. Although 30-day mortality after DVT remained fairly constant over the last 3 decades, it improved markedly for PE.

摘要

背景

静脉血栓栓塞症(VTE)后长期死亡率的研究较少。

方法和结果

我们使用丹麦医疗数据库,对 1980 年至 2011 年间首次发生 VTE(深静脉血栓形成[DVT]和肺栓塞[PE])的 128223 例患者和通过性别、出生年份和日历期随机匹配的来自普通人群(无 VTE)的 640760 人进行了一项 30 年全国性基于人群的队列研究。与对照组相比,DVT 和 PE 患者在发病后的第一年,尤其是在发病后的前 30 天内(3.0%和 31% vs. 0.4%)死亡率明显升高。我们使用 Cox 回归评估了死亡率比值比(MRR)及其 95%置信区间(CI)。DVT 的 30 年总 MRR 为 1.55(95%CI,1.53-1.57),PE 为 2.77(95%CI,2.74-2.81)。DVT 的 30 天 MRR 为 5.38(95%CI,5.00-5.80),PE 为 80.87(95%CI,76.02-86.02)。随着时间的推移,DVT 的 30 天 MRR 持续增加了 5-6 倍,而 PE 则从 1980 年至 1989 年的 138(95%CI,125-153)增加到 2000 年至 2011 年的 36.08(95%CI,32.65-39.87)。DVT 和 PE 后 1-10 年和 11-30 年的 MRR 仍增加了 25%-40%,但 DVT 后增加了 3-5 倍,PE 后增加了 6-11 倍,当 VTE 被认为是直接死亡原因时。

结论

VTE 患者的死亡风险增加,尤其是在诊断后的第一年,但在整个 30 年的随访中也是如此,VTE 是死亡的一个重要原因。尽管过去 30 年来 DVT 后 30 天的死亡率相对稳定,但 PE 的死亡率显著改善。

相似文献

1
30-year mortality after venous thromboembolism: a population-based cohort study.静脉血栓栓塞 30 年后的死亡率:一项基于人群的队列研究。
Circulation. 2014 Sep 2;130(10):829-36. doi: 10.1161/CIRCULATIONAHA.114.009107. Epub 2014 Jun 26.
2
Anticoagulant therapy after venous thromboembolism and 10-year mortality.静脉血栓栓塞后的抗凝治疗与10年死亡率
Int J Cardiol. 2016 Apr 1;208:72-8. doi: 10.1016/j.ijcard.2016.01.190. Epub 2016 Jan 18.
3
Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism.肝硬化与静脉血栓栓塞后30天死亡率增加相关。
Clin Transl Gastroenterol. 2015 Jul 2;6(7):e97. doi: 10.1038/ctg.2015.27.
4
Sex differences in risk of incident venous thromboembolism in heart failure patients.心力衰竭患者静脉血栓栓塞事件风险的性别差异。
Clin Res Cardiol. 2019 Jan;108(1):101-109. doi: 10.1007/s00392-018-1329-9. Epub 2018 Aug 21.
5
Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study.人体身高与静脉血栓栓塞发生率的性别差异:一项丹麦随访研究。
Eur J Intern Med. 2010 Aug;21(4):268-72. doi: 10.1016/j.ejim.2010.03.013. Epub 2010 Apr 28.
6
The Prevalence of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism After Anterior Cruciate Ligament Reconstruction.前交叉韧带重建术后有症状的深静脉血栓形成和肺栓塞的患病率
Am J Sports Med. 2015 Nov;43(11):2714-9. doi: 10.1177/0363546515601970. Epub 2015 Sep 21.
7
Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study.丹麦脾静脉血栓形成患者的出血风险和动脉心血管事件:一项基于人群的队列研究。
Lancet Haematol. 2018 Oct;5(10):e441-e449. doi: 10.1016/S2352-3026(18)30133-9. Epub 2018 Sep 7.
8
Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.金黄色葡萄球菌菌血症后一年内静脉血栓栓塞风险增加:一项全国性观察性匹配队列研究。
J Intern Med. 2014 Apr;275(4):387-97. doi: 10.1111/joim.12147. Epub 2013 Nov 1.
9
Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.心房颤动与静脉血栓栓塞风险增加相关。一项基于人群的队列研究。
Thromb Haemost. 2015 Jan;113(1):185-92. doi: 10.1160/TH14-05-0405. Epub 2014 Oct 16.
10
Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study.多发性硬化症与静脉血栓栓塞风险:基于人群的队列研究。
Neuroepidemiology. 2012;38(2):76-83. doi: 10.1159/000335496. Epub 2012 Jan 27.

引用本文的文献

1
Two sides of the coin: coagulation and inflammation in deep vein thrombosis - a prospective study on D-dimer and SIRI.硬币的两面:深静脉血栓形成中的凝血与炎症——一项关于D-二聚体和全身炎症反应指数的前瞻性研究
Front Med (Lausanne). 2025 Aug 11;12:1604286. doi: 10.3389/fmed.2025.1604286. eCollection 2025.
2
Appropriate target range of INR and predictive factors of recurrent thrombosis and bleeding in patients with venous thromboembolism on warfarin.华法林治疗静脉血栓栓塞症患者的国际标准化比值(INR)适宜目标范围及复发血栓形成和出血的预测因素
Sci Rep. 2025 Jul 2;15(1):23463. doi: 10.1038/s41598-025-08229-2.
3
Cohort Profile: - A Linkage Between Danish National Health Surveys and Health Registers.
队列简介:丹麦国家健康调查与健康登记册之间的联系。
Clin Epidemiol. 2025 May 29;17:485-495. doi: 10.2147/CLEP.S522468. eCollection 2025.
4
Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery.胰腺癌手术后延长静脉血栓栓塞预防措施的差异。
Ann Surg Oncol. 2025 May 24. doi: 10.1245/s10434-025-17465-9.
5
Multimorbidity and Venous Thromboembolism: Epidemiological Evidence, Pathophysiology, Prophylactic and Therapeutic Anticoagulation Efficacy, Safety, and Difficulties. A Review.多重疾病与静脉血栓栓塞:流行病学证据、病理生理学、预防性和治疗性抗凝的疗效、安全性及难点。综述
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251333786. doi: 10.1177/10760296251333786. Epub 2025 Apr 15.
6
Role of Artificial Intelligence in the Diagnosis and Management of Pulmonary Embolism: A Comprehensive Review.人工智能在肺栓塞诊断与管理中的作用:全面综述
Diagnostics (Basel). 2025 Apr 1;15(7):889. doi: 10.3390/diagnostics15070889.
7
Investigation on the Implementation of Mechanical Prophylaxis Procedures for Deep Venous Thrombosis in ICU in Southwest China: A Cross-Sectional Study.中国西南地区重症监护病房深静脉血栓形成机械预防措施实施情况调查:一项横断面研究
Clin Respir J. 2025 Mar;19(3):e70069. doi: 10.1111/crj.70069.
8
Anticoagulants utilization in eight hospitals within the Luzhou region from 2019 to 2023.2019年至2023年泸州地区八家医院抗凝剂的使用情况。
PLoS One. 2025 Jan 31;20(1):e0318463. doi: 10.1371/journal.pone.0318463. eCollection 2025.
9
Prophylactic direct oral anticoagulants vs. low molecular weight heparin after urological surgery: A systematic review and meta-analysis.泌尿外科手术后预防性直接口服抗凝剂与低分子量肝素的比较:一项系统评价和荟萃分析。
Arab J Urol. 2024 Sep 18;23(1):84-94. doi: 10.1080/20905998.2024.2395202. eCollection 2025.
10
Anticoagulation at the end of life: whether, when, and how to treat.临终时的抗凝治疗:是否进行治疗、何时治疗以及如何治疗。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):348-354. doi: 10.1182/hematology.2024000559.